| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acknowledgement to Referees
|
|
|
|
24 |
6 |
p. 703-706
|
article
|
| 2 |
A Clinicians Guide to Recommending Common Cholesterol-Lowering Dietary Supplements
|
Backes, James M.
|
|
|
24 |
6 |
p. 719-728
|
article
|
| 3 |
A Real‑World Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) for Mavacamten
|
Yukselen, Zeynep
|
|
|
24 |
6 |
p. 791-799
|
article
|
| 4 |
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
|
Bertolet, Barry D.
|
|
|
24 |
6 |
p. 729-741
|
article
|
| 5 |
Dapagliflozin in Heart Failure: A Comprehensive Meta-analysis on Functional Capacity, Symptoms, and Safety Outcomes
|
Addo, Basilio
|
|
|
24 |
6 |
p. 753-773
|
article
|
| 6 |
Differences in Healthcare Resource Use and Cost by Pharmacotherapy Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of Claims Data
|
Butzner, Michael
|
|
|
24 |
6 |
p. 801-811
|
article
|
| 7 |
Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants
|
Angeli, Francesco
|
|
|
24 |
6 |
p. 813-821
|
article
|
| 8 |
Safety and Effectiveness of Direct Oral Anticoagulants Versus Warfarin in Patients with Venous Thromboembolism using Real-World Data: A Systematic Review and Meta-Analysis
|
Alshahrani, Walaa A.
|
|
|
24 |
6 |
p. 823-839
|
article
|
| 9 |
SGLT2 Inhibitor Prescribing in Cardiovascular-Kidney-Metabolic Syndrome
|
Beers, Brandon D.
|
|
|
24 |
6 |
p. 841-844
|
article
|
| 10 |
SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art
|
Aristizábal-Colorado, David
|
|
|
24 |
6 |
p. 707-718
|
article
|
| 11 |
The Efficacy and Safety of Levosimendan in Patients with Advanced Heart Failure: An Updated Meta-Analysis of Randomized Controlled Trials
|
Elsaeidy, Ahmed Saad
|
|
|
24 |
6 |
p. 775-790
|
article
|
| 12 |
Time Gained to Cardiovascular Disease by Intensive Lipid-Lowering Therapy: Results of Individual Placebo-Controlled Trials and Pooled Effects
|
van Bruggen, Folkert H.
|
|
|
24 |
6 |
p. 743-752
|
article
|
Journal description